Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Breast Cancer

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Pathol
2 Am J Surg
3 Ann Oncol
8 Ann Surg Oncol
9 BMC Cancer
1 Br J Cancer
3 Breast Cancer
2 Breast Cancer (Auckl)
1 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
10 Breast Cancer Res Treat
1 Breast J
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
1 Cell
4 Clin Breast Cancer
2 Eur Radiol
1 Genes Chromosomes Cancer
1 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 Nat Rev Clin Oncol
5 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. LOWRY KP, Sippo DA
    Beyond the AJR: "Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk".
    AJR Am J Roentgenol. 2020 Nov 25. doi: 10.2214/AJR.20.25138.

    Am J Pathol

  2. WANG S, Zhang X, Wang H, Wang Y, et al
    Heat Shock Protein 27 Enhances SUMOylation of Heat Shock Protein B8 to Accelerate the Progression of Breast Cancer.
    Am J Pathol. 2020;190:2464-2477.
    PubMed         Abstract available

    Am J Surg

  3. GENCO IS, Tugertimur B, Manolas PA, Hasanovic A, et al
    Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
    Am J Surg. 2020;220:677-681.
    PubMed         Abstract available

  4. JAMES TA, Palis B, McCabe R, Pardo JA, et al
    Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.
    Am J Surg. 2020;220:654-659.
    PubMed         Abstract available

    Ann Oncol

  5. ANDRE F, Ciruelos EM, Juric D, Loibl S, et al
    Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1.
    Ann Oncol. 2020 Nov 24. pii: S0923-7534(20)43166.
    PubMed         Abstract available

  6. EIKESDAL HP, Yndestad S, Elzawahry A, Llop-Guevara A, et al
    Olaparib Monotherapy as Primary Treatment in Unselected Triple Negative Breast Cancer.
    Ann Oncol. 2020 Nov 23. pii: S0923-7534(20)43164.
    PubMed         Abstract available

  7. MAGBANUA MJM, Swigart LB, Wu HT, Hirst GL, et al
    Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
    Ann Oncol. 2020 Nov 21. pii: S0923-7534(20)43162.
    PubMed         Abstract available

    Ann Surg Oncol

  8. SALMINEN SH, Blomqvist CP
    ASO Author Reflections: Registry-Based Analysis of Radiation-Associated Angiosarcoma of the Breast Provides Unbiased Insights into this Disease.
    Ann Surg Oncol. 2020;27:1011-1012.

  9. LEONARDI MC, Tomio L, Radice D, Takanen S, et al
    Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
    Ann Surg Oncol. 2020;27:752-762.
    PubMed         Abstract available

  10. PADILLA-RUIZ M, Redondo M
    ASO Author Reflections: Predictive Factors for Surgical Treatment Delay in Localised Breast Cancer.
    Ann Surg Oncol. 2020 Nov 24. pii: 10.1245/s10434-020-09411.

    ASO Author Reflections: Repeat Quadrantectomy and Re-irradiation Is Safe and Effective Treatment for Local Recurrence After Partial Breast Irradiation.
    Ann Surg Oncol. 2020;27:763-764.

  12. KAUFMAN CS, Cross MJ, Barone JL, Dekhne NS, et al
    A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Patients with Breast Cancer.
    Ann Surg Oncol. 2020 Nov 21. pii: 10.1245/s10434-020-09271.
    PubMed         Abstract available

  13. TAMIRISA N, Lei X, Caudle AS, Giordano SH, et al
    Impact of SSO-ASTRO "No Ink on Tumor" Guidelines on Reexcision Rates among Older Breast Cancer Patients.
    Ann Surg Oncol. 2020 Nov 22. pii: 10.1245/s10434-020-09370.
    PubMed         Abstract available

  14. PADILLA-RUIZ M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Tellez T, et al
    Factors that Influence Treatment Delay for Patients with Breast Cancer.
    Ann Surg Oncol. 2020 Nov 27. pii: 10.1245/s10434-020-09409.
    PubMed         Abstract available

  15. KANTOR O, Coopey SB
    Axillary Downstaging in ER(+)/HER(2-) Breast Cancer: OncotypeDX As a Tool to Guide Neoadjuvant Approach.
    Ann Surg Oncol. 2020 Nov 23. pii: 10.1245/s10434-020-09385.

    BMC Cancer

  16. ZHANG Z, Zheng Q, Liu Y, Sun L, et al
    Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells.
    BMC Cancer. 2020;20:1158.
    PubMed         Abstract available

  17. PESSOA-PEREIRA D, Evangelista AF, Causin RL, da Costa Vieira RA, et al
    miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
    BMC Cancer. 2020;20:143.
    PubMed         Abstract available

  18. HU G, Hu G, Zhang C, Lin X, et al
    Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
    BMC Cancer. 2020;20:136.
    PubMed         Abstract available

  19. BISWAS A, Mukherjee G, Kondaiah P, Desai KV, et al
    Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer.
    BMC Cancer. 2020;20:1159.
    PubMed         Abstract available

  20. SUN GY, Wen G, Zhang YJ, Tang Y, et al
    Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
    BMC Cancer. 2020;20:1155.
    PubMed         Abstract available

  21. WANG J, Tang Y, Jing H, Sun G, et al
    Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy.
    BMC Cancer. 2020;20:1132.
    PubMed         Abstract available

  22. ZHANG L, Tang R, Deng JP, Zhang WW, et al
    The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
    BMC Cancer. 2020;20:1146.
    PubMed         Abstract available

  23. GAO ZH, Li CX, Liu M, Jiang JY, et al
    Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    BMC Cancer. 2020;20:1150.
    PubMed         Abstract available

  24. BERGER E, Maitre N, Romana Mancini F, Baglietto L, et al
    The impact of lifecourse socio-economic position and individual social mobility on breast cancer risk.
    BMC Cancer. 2020;20:1138.
    PubMed         Abstract available

    Br J Cancer

  25. RIGGIO AI, Varley KE, Welm AL
    The lingering mysteries of metastatic recurrence in breast cancer.
    Br J Cancer. 2020 Nov 26. pii: 10.1038/s41416-020-01161.
    PubMed         Abstract available

    Breast Cancer

  26. MU G, Ji H, He H, Wang H, et al
    Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
    Breast Cancer. 2020 Nov 27. pii: 10.1007/s12282-020-01191.
    PubMed         Abstract available

  27. WANG B, Yan T, Sun L, Zhang G, et al
    A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction.
    Breast Cancer. 2020 Nov 26. pii: 10.1007/s12282-020-01190.
    PubMed         Abstract available

  28. WU X, Zhang X, Hao Y, Li J, et al
    Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews.
    Breast Cancer. 2020 Nov 25. pii: 10.1007/s12282-020-01182.
    PubMed         Abstract available

    Breast Cancer (Auckl)

  29. DUTTA D, Palmer XL, Ortega-Rodas J, Balraj V, et al
    Biomechanical and Biophysical Properties of Breast Cancer Cells Under Varying Glycemic Regimens.
    Breast Cancer (Auckl). 2020;14:1178223420972362.
    PubMed         Abstract available

  30. SNYDER KK, Van Buskirk RG, Baust JG, Baust JM, et al
    Breast Cancer Cryoablation: Assessment of the Impact of Fundamental Procedural Variables in an In Vitro Human Breast Cancer Model.
    Breast Cancer (Auckl). 2020;14:1178223420972363.
    PubMed         Abstract available

    Breast Cancer (Dove Med Press)

    Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data.
    Breast Cancer (Dove Med Press). 2020;12:251-258.
    PubMed         Abstract available

    Breast Cancer Res

  32. JORDAN KR, Hall JK, Schedin T, Borakove M, et al
    Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
    Breast Cancer Res. 2020;22:128.
    PubMed         Abstract available

  33. WANG SM, Pfeiffer RM, Gierach GL, Falk RT, et al
    Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Breast Cancer Res. 2020;22:129.
    PubMed         Abstract available

  34. LEE KM, Lee H, Han D, Moon WK, et al
    Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer.
    Breast Cancer Res. 2020;22:130.
    PubMed         Abstract available

    Breast Cancer Res Treat

  35. LI AC, Zhao J, Zhao C, Ma Z, et al
    Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
    Breast Cancer Res Treat. 2020;180:321-329.
    PubMed         Abstract available

  36. SEOW DYB, Yeong JPS, Lim JX, Chia N, et al
    Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
    Breast Cancer Res Treat. 2020;180:369-377.
    PubMed         Abstract available

  37. STUMPF CC, Zucatto AE, Cavalheiro JAC, de Melo MP, et al
    Oncologic safety of immediate autologous fat grafting for reconstruction in breast-conserving surgery.
    Breast Cancer Res Treat. 2020;180:301-309.
    PubMed         Abstract available

  38. SUNAGUCHI N, Shimao D, Yuasa T, Ichihara S, et al
    Three-dimensional microanatomy of human nipple visualized by X-ray dark-field computed tomography.
    Breast Cancer Res Treat. 2020;180:397-405.
    PubMed         Abstract available

  39. RICHMAN J, Ring A, Dowsett M, Sestak I, et al
    Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.
    Breast Cancer Res Treat. 2020 Nov 21. pii: 10.1007/s10549-020-06013.
    PubMed         Abstract available

  40. BRAAL CL, Hussaarts KGAM, Seuren L, Oomen-deHoop E, et al
    Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
    Breast Cancer Res Treat. 2020 Nov 23. pii: 10.1007/s10549-020-05979.
    PubMed         Abstract available

  41. PAK LM, Gaither R, Rosenberg SM, Ruddy KJ, et al
    Tumor phenotype and concordance in synchronous bilateral breast cancer in young women.
    Breast Cancer Res Treat. 2020 Nov 26. pii: 10.1007/s10549-020-06027.
    PubMed         Abstract available

  42. SHAH C, Zambelli-Weiner A, Delgado N, Sier A, et al
    The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Breast Cancer Res Treat. 2020 Nov 27. pii: 10.1007/s10549-020-05988.
    PubMed         Abstract available

  43. KATZ MS, McCall L, Ballman K, Jagsi R, et al
    Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations.
    Breast Cancer Res Treat. 2020;180:429-436.
    PubMed         Abstract available

  44. PING J, Huang S, Wu J, Bao P, et al
    Association between lincRNA expression and overall survival for patients with triple-negative breast cancer.
    Breast Cancer Res Treat. 2020 Nov 27. pii: 10.1007/s10549-020-06021.
    PubMed         Abstract available

    Breast J

  45. ARAIN A
    Smoking among breast cancer survivors.
    Breast J. 2020 Nov 28. doi: 10.1111/tbj.14107.


  46. PARK J, Rodriguez JL, O'Brien KM, Nichols HB, et al
    Health-related quality of life outcomes among breast cancer survivors.
    Cancer. 2020 Nov 25. doi: 10.1002/cncr.33348.
    PubMed         Abstract available

  47. PRINTZ C
    Early breast cancer screening in childhood cancer survivors treated with chest radiation may reduce deaths by more than 50.
    Cancer. 2020;126:5197.

    Cancer Epidemiol Biomarkers Prev

  48. QIN B, Babel RA, Plascak JJ, Lin Y, et al
    Neighborhood social environmental factors and breast cancer subtypes among Black women.
    Cancer Epidemiol Biomarkers Prev. 2020 Nov 24. pii: 1055-9965.EPI-20-1055.
    PubMed         Abstract available

    Cancer Res

  49. DAVRA V, Kumar S, Geng K, Calianese D, et al
    Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host anti-tumor immunity.
    Cancer Res. 2020 Nov 25. pii: 0008-5472.CAN-20-2066.
    PubMed         Abstract available


  50. ZHOU AY
    Choosing a New Direction on a One-Way Street.
    Cell. 2020;181:212-218.

    Clin Breast Cancer

  51. KORUCU TS, Ucurum SG, Tastaban E, Ozgun H, et al
    Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery.
    Clin Breast Cancer. 2020 Oct 29. pii: S1526-8209(20)30267.
    PubMed         Abstract available

  52. TAKALA L, Kuusinen TE, Skytta T, Kellokumpu-Lehtinen PL, et al
    Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
    Clin Breast Cancer. 2020 Oct 20. pii: S1526-8209(20)30263.
    PubMed         Abstract available

  53. BRENES SANCHEZ JM, Picado AL, Olivares Crespo ME, Garcia Saenz JA, et al
    Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
    Clin Breast Cancer. 2020 Oct 24. pii: S1526-8209(20)30265.
    PubMed         Abstract available

  54. MORANTE Z, Ruiz R, Araujo JM, Pinto JA, et al
    Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30235.
    PubMed         Abstract available

    Eur Radiol

  55. LIU Z, Li X, Feng B, Li C, et al
    MIP image derived from abbreviated breast MRI: potential to reduce unnecessary sub-nipple biopsies during nipple-sparing mastectomy for breast cancer.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07550.
    PubMed         Abstract available

  56. JIANG M, Zhang D, Tang SC, Luo XM, et al
    Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study.
    Eur Radiol. 2020 Nov 23. pii: 10.1007/s00330-020-07544.
    PubMed         Abstract available

    Genes Chromosomes Cancer

  57. ALI RMM, McIntosh SA, Savage KI
    Homologous Recombination Deficiency in Breast Cancer: implications for risk, cancer development and therapy.
    Genes Chromosomes Cancer. 2020 Nov 27. doi: 10.1002/gcc.22921.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  58. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed         Abstract available

    J Biol Chem

  59. WU Q, Zhang C, Zhang K, Chen Q, et al
    ppGalNAc-T4-catalyzed O-Glycosylation of TGF-beta type receptor regulates breast cancer cells metastasis.
    J Biol Chem. 2020 Nov 24. pii: RA120.016345. doi: 10.1074/jbc.RA120.016345.
    PubMed         Abstract available


    Long-term Mortality Outcomes in Early Breast Cancer Screening Trial.
    JAMA. 2020;324:2020.

    Nat Rev Clin Oncol

    CDK4/6 inhibitors for HR(+)HER2(-) early stage breast cancer - when to escalate treatment?
    Nat Rev Clin Oncol. 2020 Nov 24. pii: 10.1038/s41571-020-00453.


  62. AL-ZAHRANI KN, Abou-Hamad J, Cook DP, Pryce BR, et al
    Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers.
    Oncogene. 2020;39:4592-4602.
    PubMed         Abstract available

  63. TABATABAEIAN H, Rao A, Ramos A, Chu T, et al
    The emerging roles of WBP2 oncogene in human cancers.
    Oncogene. 2020;39:4621-4635.
    PubMed         Abstract available

  64. HSU BE, Roy J, Mouhanna J, Rayes RF, et al
    C3a elicits unique migratory responses in immature low-density neutrophils.
    Oncogene. 2020;39:2612-2623.
    PubMed         Abstract available

  65. LEFORT S, Tan S, Balani S, Rafn B, et al
    Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation.
    Oncogene. 2020;39:1957-1968.
    PubMed         Abstract available

  66. ATTALLA S, Taifour T, Bui T, Muller W, et al
    Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
    Oncogene. 2020 Nov 24. pii: 10.1038/s41388-020-01560.
    PubMed         Abstract available

    PLoS One

  67. AFRIN K, Iquebal AS, Karimi M, Souris A, et al
    Directionally dependent multi-view clustering using copula model.
    PLoS One. 2020;15:e0238996.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  68. LOEILLET S, Herzog M, Puddu F, Legoix P, et al
    Trajectory and uniqueness of mutational signatures in yeast mutators.
    Proc Natl Acad Sci U S A. 2020;117:24947-24956.
    PubMed         Abstract available

    Radiother Oncol

  69. CJ BOSMA S, Hoogstraat M, van Werkhoven E, de Maaker M, et al
    A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31195.

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.